Knocking down CypA reverses the paclitaxel resistance via suppression of MAPK kinase pathways.115 Peng et al. revealed that CypA is upregulated in chemoresistant colorectal cancer (CRC) samples. The gene discussed is PPIA; the disease is colorectal carcinoma.